Shares of Gland Pharma rallied 11.06% to an intraday high of Rs 2,075 during Monday’s trading session after the company reported a sharp rise in revenue and profitability for the fourth quarter of FY26, along with the announcement of a final dividend.
The pharmaceutical company's robust performance in Q4 FY26 was driven by strong growth in its CDMO business, improved operational efficiency, and healthy demand across key markets.
